|The Malaria HRP2 n/a (Catalog #MBS838104) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Malaria HRP2 antibody reacts with Not determined. Specific of Histidine Rich Protein-II and may cross-react with other species as described in the data sheet.
MBS838104 can be used as a capture antibody in a matched pair immunoassay in conjunction with MBS838354 as the detection antibody. Researchers should empirically determine the suitability of the Malaria HRP2 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal Malaria HRP2 antibody.
Biological Significance: At least five malaria proteins (HRP1, HRP2, EMP1, EMP2, and EMP3) have been identified in the surface or in association with the cytoskeleton of erythrocytes infected with Plasmodium falciparum. HRP2 is a histidine- and alanine-rich protein, which is localized in several cell compartments including the parasite cytoplasm. Currently the principal application of of HRP2 is for the diagnosis of malaria by detection of P. falciparum HRP2 antigen with a rapid dipstick antigen-capture assay or ELISA. Immunogen: Malaria HRP2 antibody was raised in mouse using recombinant Malaria HRP-2 antigen
Additional Remarks: Use for conjugation or capture. Not recommended for pairing to itself. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Malaria HRP2 are readily searchable from our website. Different antibodies against the same target such as Malaria HRP2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.